Healixa Inc(EMOR)
$0.040.00 (0.00%)
EMOR
Healixa Inc financials statements
$0.04
At close:0.00 (0.00%)
Healixa Inc (EMOR) Ratios
8 Followers
Healixa Inc Ratios
EMOR's free cash flow for Q1 2026 was $-119.45K. For the 2026 fiscal year, EMOR's free cash flow was decreased by $-4.00 and operating cash flow was $-119.45K. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.03 | 0.02 | 0.04 | 0.03 | 0.03 |
| Quick Ratio | 0.03 | 0.02 | 0.04 | 0.03 | 0.03 |
| Cash Ratio | 0.02 | 0.00 | 0.01 | 0.00 | 0.02 |
| Solvency Ratio | -0.06 | -0.08 | -0.63 | -0.05 | -0.45 |
| Operating Cash Flow Ratio | 0.00 | -0.03 | -0.08 | -0.19 | -0.27 |
| Short-Term Operating Cash Flow Coverage | 0.00 | -0.04 | -0.13 | -0.38 | -0.53 |
| Net Current Asset Value | $ -9.58M | $ -9.01M | $ -10.11M | $ -11.08M | $ -6.11M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 20.88 | 28.62 | 10.55 | 9.96 | 8.40 |
| Debt-to-Equity Ratio | -0.70 | -0.73 | -0.66 | -0.51 | -0.55 |
| Debt-to-Capital Ratio | -2.30 | -2.65 | -1.97 | -1.06 | -1.20 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | -0.03 | -0.03 | -0.06 | -0.05 | -0.07 |
| Debt Service Coverage Ratio | -0.15 | -0.07 | -0.91 | -0.09 | -0.76 |
| Interest Coverage Ratio | -3.17 | -1.69 | -16.71 | -1.01 | -11.71 |
| Debt to Market Cap | 0.22 | 0.21 | 0.06 | 0.04 | 0.00 |
| Interest Debt Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 |
| Net Debt to EBITDA | -6.34 | -14.02 | -1.03 | -10.69 | -1.19 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | 56.07% | 35.20% | -275.29% | 0.00% |
| EBIT Margin | 1083.29% | -67.60% | -1060.88% | -6292.10% | 0.00% |
| EBITDA Margin | 1083.29% | -66.02% | -1055.35% | -5916.81% | 0.00% |
| Operating Profit Margin | 1083.29% | -67.60% | -1060.88% | -6292.11% | 0.00% |
| Pretax Profit Margin | 599.38% | -107.68% | -1123.79% | -7316.07% | 0.00% |
| Net Profit Margin | 599.38% | -107.68% | -1123.79% | -7316.07% | 0.00% |
| Continuous Operations Profit Margin | 599.38% | -107.68% | -1123.79% | -7316.07% | 0.00% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 55.33% | 159.30% | 105.93% | 116.27% | 108.54% |
| Return on Assets (ROA) | -177.04% | -331.04% | -1076.89% | -114.71% | -738.90% |
| Return on Equity (ROE) | 5.91% | 8.40% | 67.65% | 5.93% | 48.04% |
| Return on Capital Employed (ROCE) | 10.68% | 5.27% | 63.86% | 5.10% | 44.45% |
| Return on Invested Capital (ROIC) | 35.25% | 19.25% | 189.50% | 10.51% | 97.55% |
| Return on Tangible Assets | -177.04% | -331.04% | -1319.73% | -194.01% | -1837.04% |
| Earnings Yield | -1.85% | -2.47% | -6.22% | -0.46% | -0.40% |
| Efficiency Ratios | |||||
| Receivables Turnover | -3.37 | 3.81 | 2.46 | 1.43 | 0.00 |
| Payables Turnover | 0.00 | 0.59 | 0.63 | 0.03 | 0.05 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.00 | 54.26 | 0.20 | 0.00 |
| Asset Turnover | -0.30 | 3.07 | 0.96 | 0.02 | 0.00 |
| Working Capital Turnover Ratio | 0.01 | -0.07 | -0.06 | -0.00 | 0.00 |
| Cash Conversion Cycle | -108.21 | -517.90 | -429.84 | -13608.19 | -6797.86 |
| Days of Sales Outstanding | -108.21 | 95.81 | 148.14 | 255.77 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 0.00 | 613.71 | 577.98 | 13863.96 | 6797.86 |
| Operating Cycle | -108.21 | 95.81 | 148.14 | 255.77 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Free Cash Flow Per Share | 0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Dividend Paid and CapEx Coverage Ratio | 7801.00 | -66351.50 | -219841.50 | 0.00 | -14.73 |
| Capital Expenditure Coverage Ratio | 7801.00 | -66351.50 | -219841.50 | 0.00 | -14.73 |
| Operating Cash Flow Coverage Ratio | 0.00 | -0.04 | -0.13 | -0.38 | -0.52 |
| Operating Cash Flow to Sales Ratio | -0.25 | -0.38 | -1.47 | -242.50 | 0.00 |
| Free Cash Flow Yield | 0.08% | -0.87% | -0.81% | -1.53% | -0.25% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -54.18 | -40.00 | -16.08 | -216.99 | -252.93 |
| Price-to-Sales (P/S) Ratio | -324.74 | 43.63 | 180.65 | 15875.43 | 0.00 |
| Price-to-Book (P/B) Ratio | -3.20 | -3.40 | -10.87 | -12.86 | -121.52 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 1310.64 | -115.55 | -123.03 | -65.47 | -397.50 |
| Price-to-Operating Cash Flow Ratio | 1310.47 | -115.55 | -123.03 | -65.47 | -424.48 |
| Price-to-Earnings Growth (PEG) Ratio | 0.54 | 0.45 | -0.02 | 2.81 | 3.12 |
| Enterprise Value Multiple | -36.31 | -80.10 | -18.15 | -279.00 | -278.16 |
| Enterprise Value | 37.15M | 37.17M | 114.70M | 145.63M | 722.16M |
| EV to EBITDA | -36.31 | -80.10 | -18.15 | -279.00 | -278.16 |
| EV to Sales | -393.37 | 52.88 | 191.51 | 16507.94 | 0.00 |
| EV to Free Cash Flow | 1587.62 | -140.06 | -130.43 | -68.07 | -399.21 |
| EV to Operating Cash Flow | 1587.41 | -140.06 | -130.43 | -68.07 | -426.31 |
| Tangible Book Value Per Share | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Shareholders’ Equity Per Share | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | -0.00 | 0.00 | 0.00 |
| Revenue Per Share | -0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -0.00 | -0.00 | -0.01 | -0.00 | -0.00 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 0.55 | 1.59 | 1.06 | 1.16 | 1.09 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | -9.83 | 1.24 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | -0.04 | 0.35 | 0.13 | 3.31 | 0.60 |
Currency in USD

